IGM Biosciences Cash Flow Statement 2017-2024 | IGMS

Fifteen years of historical annual cash flow statements for IGM Biosciences (IGMS).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
2023202220212020201920182017
$-246.42$-221.10$-165.16$-81.36$-43.13$-22.71$-11.05
$-0.86$3.36$5.11$1.00$0.29$0.28$0.16
$61.74$56.72$28.63$10.43$2.75$0.21$0.09
$60.88$60.08$33.74$11.43$3.04$0.49$0.25
$0$0$0$0$0$0$0
$0$0$0$0$0$0$0
$-0.99$-3.00$0.65$2.20$1.96$-0.06$0.13
$-2.49$144$-6.77$-3.03$-6.96$-0.39$0.00
$-6.69$155$6.45$2.05$-5.02$2.18$0.44
$-192.23$-5.85$-124.98$-67.88$-45.12$-20.04$-10.36
$-12.38$-10.21$-13.24$-17.50$-2.34$-0.79$-0.39
$0$0$0$0$0$0$0
$0$0$0$0$0$0$0
$0$0$0$0$0$0$0
$80.74$-215.44$28.71$75.79$-200.90$0$0
$80.74$-215.44$28.71$75.79$-200.90$0$0
$0$0$0$0$0$0$0
$68.36$-225.64$15.46$58.29$-203.24$-0.79$-0.39
$0$0$0$0$0$0$0
$0$0$0$0$15.00$5.00$0
$0$0$0$0$15.00$5.00$0
$115$219$4.03$217$187$0$0.00
$115$219$4.03$217$269$17.34$8.00
$0$0$0$0$0$0$0
$0$0$-1.56$-1.73$-1.77$0$0.07
$115$219$2.48$215$282$22.34$8.07
$-8.81$-12.12$-107.05$205$33.90$1.51$-2.67
$46.55$44.71$25.87$8.45$1.01$0.18$0.09
$0$0$0$0$0$0$0